Cognition Therapeutics, Inc. (CGTX) Misses Q3 EPS by 5c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q3 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Element Solutions (ESI) to Buy, 'We would buy ESI aggressively on this news'
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM